Gene · 3913
NIH grants2,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
641 to 660 of 2,633
Download this page as JSON| Grant | Title | LAMB2 papers | Newest fiscal year |
|---|---|---|---|
| R01AR073196 | Kallikrein-PAR interactions in skin inflammation | 1 | 2023 |
| R01AR074541 | Mechanisms underlying tendon regeneration and attachment site pattern restoration | 1 | 2023 |
| R01AR075413 | Skeletal Muscle Stem Cells Derived from Teratomas | 1 | 2023 |
| R01CA059655 | Regulation of Human Papillomavirus Gene Expression | 1 | 2023 |
| R01CA174798 | Endothelial-to-osteoblast transition in prostate cancer bone metastasis | 1 | 2023 |
| R01CA177670 | The Impact of Macrophage Origin on the Pathogenesis and Treatment Resistance of Pancreatic Cancer | 1 | 2023 |
| R01CA189532 | Statistical Methods for Analysis of Tumor Heterogeneity in Genetic Epidemiology | 1 | 2023 |
| R01CA225463 | Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway | 1 | 2023 |
| R01CA229164 | Novel Degraders of the Androgen Receptor (AR) and AR Splice Variants (AR-SVs) | 1 | 2023 |
| R01CA234553 | Role of the microenvironment in ovarian cancer metastasis | 1 | 2023 |
| R01CA235412 | Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression | 1 | 2023 |
| R01CA237165 | The roles of SOCS5 in T-ALL migration and tissue infiltration | 1 | 2023 |
| R01CA240924 | Reverse transcriptase inhibitor effects on the mobilome of colon cancer | 1 | 2023 |
| R01CA240993 | Structural and molecular determinants of protein phosphatase 2A function in lung cancer | 1 | 2023 |
| R01DA034231 | MOR and CCR5 interactive signaling mediates opiate and HIV-driven synaptodendritic injury | 1 | 2023 |
| R01DC017139 | Optimal Tissue Engineering Approach for Treating Injured Vocal Folds | 1 | 2023 |
| R01DE016523 | Clickable Microgel Scaffolds for MSC Expansion and Delivery | 1 | 2023 |
| R01DE028282 | Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer | 1 | 2023 |
| R01DE028420 | Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCC | 1 | 2023 |
| R01DE029166 | Ineffective wound healing responses enable chronic radiation-induced salivary gland dysfunction | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/grants?page=33